MétaCan
Menu
Back to cohort

Effect of surgical resection (SR) of primary tumor in advanced colorectal cancer (CRC) on outcome: A Canadian province’s experience

2008· article· en· W2591077493 on OpenAlexaboutno aff
Sulman Ahmed, Ruqaiya Shahid, Tianyu Zhu, Kamal Haider, R. Alvi, F. Arnold, A. Sami, S. Yadav, M L Brigden, Kathleen A. Harding, Imad Ahmad

Bibliographic record

VenueJournal of Clinical Oncology · 2008
Typearticle
Languageen
FieldMedicine
TopicColorectal Cancer Treatments and Studies
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineChemotherapyPrimary tumorColorectal cancerSurgeryProportional hazards modelInternal medicineMultivariate analysisMedical recordCancerMetastasis

Abstract

fetched live from OpenAlex

15016 Background: Advances in anticancer therapy have led to improved outcomes for patients with advanced CRC. The potential benefit of SR of primary tumor in these patients remains unknown. We have recently demonstrated that SR of primary tumor in patients with newly diagnosed advanced CRC has been associated with survival benefit irrespective of chemotherapy (ASCO 2008 GI Symposium). We present here an update analysis. Methods: Medical records of patients with metastatic CRC diagnosed from 1992–2000 in Saskatchewan province were reviewed. Patients with unresectable T4M0 disease were excluded. A multivariate analysis was done using Cox regression model and various clinicopathologic variables were tested for their prognostic significance. Kaplan-Meier curves were used to determine survival. Results: A total 813 eligible patients were identified. Patients median age was 71 yrs (24–98) and M: F was 56:44. Five hundred-ninety four (73%) patients underwent SR of the primary tumor. Among 594 patients, 248 (41%) were operated for tumor related symptoms. Thirty-nine (6.5%) died within 30 days of surgery. Of 813 patients, 314 (39%) patients received 5FU-based chemotherapy and 84 (10%) received a second line therapy. Median overall survival (OS) of all patients was 7.3 months. Patients who received chemotherapy had a median OS of 14.8 months compared with 4.1 months if they did not receive chemotherapy (p<0.0001). Patients who underwent SR of primary tumor had a median OS of 9.7 months compared with 3.3 months in patients who did not have surgery (p<0.0001). Patients who had SR and received chemotherapy had a significantly better median OS of 16.7 months compared with 8.7 months if they received chemotherapy but did not have surgery (P<0.0001). On multivariate analysis 5FU-based chemotherapy (HR 0.48; 95% CI: 0.40–0.56), SR of primary tumor (HR 0.49; 95%CI: 0.42–0.59), and metastectomy (HR 0.58; 95% CI: 0.46–0.71) were correlated with a better survival in patients with advanced CRC. Conclusions: SR of primary tumor in patients with advanced CRC has been associated with significant improvement in survival independent of systemic chemotherapy. A future prospective trial is warranted to assess the role of SR of primary tumor in the era of targeted therapy. No significant financial relationships to disclose.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.026
Threshold uncertainty score0.183

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.002
Science and technology studies0.0020.001
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.078
GPT teacher head0.464
Teacher spread0.386 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2008
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicColorectal Cancer Treatments and StudiesFrench-language works237,207